Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Lansing-East Lansing, MI MSA — October 2026
Lansing's labor force is shrinking while specialist pay diverges by role.
Lansing's labor force contracted 10.2% year-over-year even as Validation Engineer pay climbed to $110,300 and Regulatory Affairs Specialist pay fell to $94,953 — a split market demanding role-by-role compensation review.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Lansing labor force decline: -10.2% — Steepest of 18 Michigan metro areas, Sept. 2026
- Lansing unemployment rate: 4.6% — Down from 4.9% a year ago, Aug. 2026
- Michigan bioindustry employment: 47,815 jobs — Up 42% since 2006, hiring moderating post-2022
- National biopharma quit rate: 1.9% — Signals specialists staying put despite hiring rebound
Key takeaways
Validation Engineer pay is pulling away from the national trend.
Metro median advertised pay for Validation Engineers rose to $110,300, a significant gain against a flat national median of $106,478. That divergence is consistent with intensifying local competition for biomanufacturing and quality-adjacent credentials as CDMOs nationally compete for scarce bioprocess expertise.
Regulatory Affairs pay is falling even as the role gets harder to fill.
Lansing's advertised median for Regulatory Affairs Specialists dropped significantly to $94,953, against a national figure of $103,780 that is also declining but more moderately. A falling rate alongside persistent national reports of regulatory talent scarcity may suggest employers are posting lower, less competitive rates than the market will bear — a pattern worth testing against actual time-to-fill data before assuming it reflects a softening in demand.
Clinical Research Associate pay is accelerating faster locally than nationally.
Metro CRA median reached $104,168, a moderate increase, while the national median climbed to $90,065 on a significant year-over-year gain — pushing the local premium wider. With national quit rates for experienced CRAs still low at 1.9%, this looks like a retention play by incumbent employers amid limited growth in new postings.
A shrinking labor force narrows the bench for specialized hires.
Lansing's labor force contracted 10.2% year-over-year, the steepest drop among Michigan's 18 labor market areas, even as unemployment held near 4.6%. Fewer active job seekers in a market already short on life sciences infrastructure raises the practical cost of in-market recruitment for quality, clinical, and regulatory functions.
Median advertised pay by role — Lansing-East Lansing, MI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $110,124 | $134,739 | $146,679 | Significant increase | $130,339 |
| Clinical Research Associate | $82,175 | $104,168 | $112,819 | Moderate increase | $90,065 |
| Lab Technician | $39,520 | $44,161 | $44,720 | Stable | $47,840 |
| Regulatory Affairs Specialist | $73,191 | $94,953 | $112,308 | Significant decline | $103,780 |
| Clinical Data Manager | $96,557 | $126,047 | $142,181 | Moderate increase | $123,653 |
| Biostatistician | $111,745 | $127,925 | $139,166 | Moderate decline | $131,958 |
| Validation Engineer * | $82,514 | $110,300 | $120,327 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Lansing's headline unemployment rate sits at 4.6%, but that stability masks a labor force that contracted 10.2% year-over-year through September — the steepest decline of any Michigan metro and a signal that workers are exiting the market without finding jobs within it. Dakkota Integrated Systems' October WARN filing for 67 manufacturing jobs adds to a thinning advertiser base, while Michigan State University's 220 open positions underscore how few large regional employers are still competing actively for talent.
What it means
Shrinking labor force participation in a metro already thin on life sciences employers raises the cost and time of specialized recruitment, particularly for regulatory, quality, and biomanufacturing roles where Michigan's statewide bioindustry base (47,815 jobs) offers limited internal mobility options. With the MI BioTalent Connect pipeline program halted before its 2026 launch, Lansing-based R&D and manufacturing leaders face a shallower local talent bench just as national data shows CRA and regulatory affairs searches remain the hardest to close. Consider reviewing whether current build-vs-outsource assumptions for clinical operations and CMC functions still hold given tightening local specialist supply, without assuming CRO/CDMO partners face the same constraints.
Looking ahead
Worth watching: Dakkota's December 31 closure will release 67 manufacturing workers into the Lansing market. Life sciences employers with quality or production technician needs may find some transferable skill overlap worth monitoring as that cohort enters the candidate pool.
Emerging pressure point: Regulatory Affairs Specialist advertised pay has fallen significantly in Lansing while national reports continue to flag the role as among the hardest to fill. Watch whether local postings begin reversing course in November as employers test higher rates to compete for scarce candidates.
Potential inflection point: Michigan's halted MI BioTalent Connect program leaves no near-term state-funded pipeline for manufacturing, quality, or clinical training. Absent a relaunch signal, expect continued reliance on relocation and premium pay to fill specialized roles, with local upskilling remaining limited.
Early indicator: Michigan State University's 220 open positions remain the largest single concentration of advertised roles in the metro. Movement in that posting count over the next two cycles will offer an early read on whether the region's largest employer is expanding or holding headcount flat into 2027 planning.
Sources
- Michigan Department of Technology, Management & Budget — Lansing MSA labor force declined 10.2% year-over-year through September 2026
- WILX News 10 — Dakkota Integrated Systems WARN notice for 67 Lansing jobs, effective Dec. 31
- Michigan biosciences industry research — Michigan bioindustry employment reached 47,815 jobs in 2024
- Michigan Strategic Fund — MI BioTalent Connect grant program halted before 2026 launch
- Industry labor market survey — National quit rate for biopharma professionals at 1.9%
- Specialized Staffing / Michigan Dept. of Technology, Management & Budget — Lansing MSA unemployment rate at 4.6% in August 2026
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.